alexidine
This page covers all alexidine drugs tracked by Drug Landscape: marketed products and active clinical-stage compounds, targeting Phosphatidylglycerophosphatase and protein-tyrosine phosphatase 1, Toll-like receptor 9, Beta-lactamase.
Targets
Phase 2 pipeline (1)
- Bisguadine · Metabolic
Bisguadine works by inhibiting phosphatidylglycerophosphatase and protein-tyrosine phosphatase 1, which are enzymes involved in cellular signaling pathways.
Patent intelligence
- alexidine patent landscape — aggregated cliff calendar, attackable patents, originator estates